Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Equity (2020 - 2025)

Oncology Institute (TOI) has disclosed Return on Equity for 6 consecutive years, with 6.24% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 938.0% year-over-year to 6.24%, compared with a TTM value of 6.24% through Sep 2025, up 938.0%, and an annual FY2024 reading of 2.13%, down 121.0% over the prior year.
  • Return on Equity was 6.24% for Q3 2025 at Oncology Institute, down from 33.65% in the prior quarter.
  • Across five years, Return on Equity topped out at 33.65% in Q2 2025 and bottomed at 14.87% in Q1 2025.
  • Average Return on Equity over 5 years is 0.4%, with a median of 0.33% recorded in 2021.
  • Peak annual rise in Return on Equity hit 3568bps in 2025, while the deepest fall reached -1338bps in 2025.
  • Year by year, Return on Equity stood at 0.12% in 2021, then surged by 101bps to 0.0% in 2022, then tumbled by -106585bps to 1.29% in 2023, then crashed by -426bps to 6.78% in 2024, then surged by 192bps to 6.24% in 2025.
  • Business Quant data shows Return on Equity for TOI at 6.24% in Q3 2025, 33.65% in Q2 2025, and 14.87% in Q1 2025.